AI assistant
ABBOTT LABORATORIES — Director's Dealing 2009
Mar 3, 2009
29777_dirs_2009-03-02_f4cf984e-6fd2-4693-9bb2-d993fcda974b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-26
Reporting Person: MAZZO JAMES V (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-02-26 | Common shares without par value | A | 20000 | — | Acquired | 20000 | Direct |
| 2008-02-26 | Common shares without par value | A | 30000 | — | Acquired | 50000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-02-26 | Option (right to buy) | $21.92 | A | 98470 | Acquired | 2012-07-29 | Common Shares (98470) | Direct |
| 2009-02-26 | Option (right to buy) | $33.76 | A | 49235 | Acquired | 2013-04-29 | Common Shares (49235) | Direct |
| 2009-02-26 | Option (right to buy) | $82.19 | A | 82058 | Acquired | 2014-05-20 | Common Shares (82058) | Direct |
| 2009-02-26 | Option (right to buy) | $93.11 | A | 75904 | Acquired | 2015-05-26 | Common Shares (75904) | Direct |
| 2009-02-26 | Option (right to buy) | $55.92 | A | 133838 | Acquired | 2018-05-29 | Common Shares (133838) | Direct |
Footnotes
F1: These shares represent non-performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program subject to an 18-month cliff vesting period.
F2: These shares represent non-performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year and include the right to have stock withheld for tax purposes.
F3: Fully vested employee stock option received pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. (the "Merger Agreement") in exchange for an employee stock option to acquire 240,000 shares of Advanced Medical Optics, Inc. common stock for $8.99 per share.
F4: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 120,000 shares of Advanced Medical Optics, Inc. common stock for $13.85 per share.
F5: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 200,000 shares of Advanced Medical Optics, Inc. common stock for $33.72 per share.
F6: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 185,000 shares of Advanced Medical Optics, Inc. common stock for $38.20 per share.
F7: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 326,200 shares of Advanced Medical Optics, Inc. common stock for $22.94 per share.